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microtubules, like those on histones,
contribute to the functional properties of
the filaments. Structural and functional
characterization of one tubulin
glutamylase reveals a general mechanism
for microtubule recognition involving
shared disorder-to-order transitions by
the enzyme and the tubulin substrate.
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Glutamylation, the most prevalent tubulin posttrans-
lational modification, marks stable microtubules and
regulates recruitment and activity of microtubule-
interacting proteins. Nine enzymes of the tubulin
tyrosine ligase-like (TTLL) family catalyze glutamyla-
tion. TTLL7, the most abundant neuronal glutamy-
lase, adds glutamates preferentially to the b-tubulin
tail. Coupled with ensemble and single-molecule
biochemistry, our hybrid X-ray and cryo-electron mi-
croscopy structure of TTLL7 bound to the microtu-
bule delineates a tripartite microtubule recognition
strategy. The enzyme uses its core to engage the
disordered anionic tails of a- and b-tubulin, and a
flexible cationic domain to bind the microtubule
and position itself for b-tail modification. Further-
more, we demonstrate that all single-chain TTLLs
with known glutamylase activity utilize a cationic
microtubule-binding domain analogous to that of
TTLL7. Therefore, our work reveals the combined
use of folded and intrinsically disordered substrate
recognition elements as the molecular basis for
specificity among the enzymes primarily responsible
for chemically diversifying cellular microtubules.INTRODUCTION
The ab-tubulin heterodimer, the basic building block of the
microtubule polymer, consists of a globular core and negatively
charged, diversely posttranslationally modified, and intrinsically
disordered C-terminal tails that decorate the microtubule exte-
rior. Most of the chemical complexity of tubulin observed in cells
arises from the differential action of tubulin tyrosine ligase (TTL)
and the homologous tubulin tyrosine ligase-like (TTLL) enzymes.
The latter are phylogenetically widespread and functionally
diversified proteins that carry out either glutamylation or glycyla-
tion of tubulin tails. These tails are in the vicinity of known binding
sites for motors and microtubule associated proteins (MAPs)1112 Cell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc.where they tune their interactions. Their chemically diverse post-
translational modifications may thus constitute a ‘‘tubulin code’’
read by cytoskeletal effectors (reviewed in Verhey and Gaertig,
2007), analogous to the histone code (Jenuwein and Allis,
2001). Understanding the molecular underpinnings for the
biochemical characteristics of TTLLs is essential to elucidate
the tubulin code, since it is the combinatorial action of these en-
zymes that generates the complexmicrotubulemodification pat-
terns observed in cells that differentiate microtubules for distinct
functions in specific tissues or subcellular structures.
Glutamylation, the most abundant tubulin posttranslational
modification in the adult mammalian brain (Audebert et al.,
1994), is the ATP-dependent addition of glutamates, either singly
or sequentially in chains, to conserved internal glutamate resi-
dues of the a- or b-tubulin tails. Glutamylation is conserved in
all metazoans as well as protists, where it is key to the assembly
and function of cilia and flagella (reviewed in Verhey and Gaertig,
2007; Garnham and Roll-Mecak, 2012). Mass spectrometry of
mammalian brain tubulin revealed a preponderance of three to
six glutamates added to both a- and b-tails at distinct conserved
locations (Alexander et al., 1991; Edde´ et al., 1990; Redeker
et al., 1992; Ru¨diger et al., 1992). The longest glutamate chains
are on axonemal microtubules (Geimer et al., 1997; Schneider
et al., 1998) and centrioles (Bobinnec et al., 1998), where tubulin
tails contain as many as 21 glutamates (Schneider et al., 1998).
Humans have nine glutamylases of the TTLL family (van Dijk
et al., 2007; reviewed in Garnham and Roll-Mecak, 2012). Of
these, TTLL7, which is conserved from the acorn worm to pri-
mates, is the most abundantly expressed in the mammalian
nervous system where it is critical for neurite outgrowth and
localization of dendritic MAPs (Ikegami et al., 2006). It is primarily
responsible for the dramatic increase in tubulin glutamylation
during postnatal neuronal maturation (Ikegami et al., 2006).
Misregulation of tubulin glutamylation leads to several physio-
logical abnormalities. Hyperglutamylation in Purkinje cell degen-
eration (pcd) mice leads to neurodegeneration (Rogowski et al.,
2010), while depressed glutamylation impairs cilia-facilitated
mucous flow, inhibits neurite outgrowth and compromises syn-
aptic function (Ikegami et al., 2007; Ikegami et al., 2006, 2010;
Janke et al., 2005). Moreover, mutations in TTLL glutamylases
or proteins required for their localization have been implicated
in several degenerative disorders including retinal dystrophy
(Sergouniotis et al., 2014) and Joubert syndrome (Lee et al.,
2012). At the molecular level, glutamylation is enriched on stable
microtubules and regulates the interaction between microtu-
bules and molecular motors or MAPs. Glutamylation enhances
the processivity of kinesin-1 and 2 (O’Hagan et al., 2011; Sirajud-
din et al., 2014), regulates inner arm dynein motility in flagella
(Kubo et al., 2010; Suryavanshi et al., 2010), and creates micro-
tubule ‘‘fast tracks’’ for efficient motor based vesicle transport
from the Golgi to the plasma membrane (Bulinski et al., 1997;
Spiliotis et al., 2008). It also modulates the binding of MAPs
tau, MAP1A and B, and MAP2 (Bonnet et al., 2001; Boucher
et al., 1994) and enhances the activity of the microtubule
severing enzymes katanin and spastin (Lacroix et al., 2010;
Roll-Mecak and Vale, 2008; Sharma et al., 2007).
Tubulin tyrosine ligase (TTL) serves as the structural blueprint
for the TTLL family of enzymes (Janke et al., 2005; Szyk et al.,
2011; van Dijk et al., 2007). TTL selectively binds to the isolated
tubulin dimer (Raybin and Flavin, 1975; Szyk et al., 2011). The
preference of TTL for the free tubulin dimer has the cellular
consequence that newly polymerized, dynamic microtubules
are enriched in tyrosination. In contrast, and despite conserva-
tion of their structural core with that of TTL (Szyk et al., 2011),
TTLLs preferentially modify the microtubule polymer (Mukai
et al., 2009; van Dijk et al., 2007), and glutamylation is enriched
on stable, long-lived microtubules. Different TTLL glutamylases
exhibit a preference for either the a- or b-tubulin tails (van Dijk
et al., 2007), and cellular motors respond differentially to a- or
b-tail glutamylation (Sirajuddin et al., 2014). To provide the
molecular basis for understanding substrate specificity within
this family of structurally homologous enzymes that are key
players in establishing the tubulin code, we have now combined
X-ray crystallography, cryo-electron microscopy (cryo-EM), and
structure-based ensemble and single-molecule biochemistry to
determine how TTLL7 recognizes and glutamylates microtu-
bules. The first structural characterization of TTLL7 and its com-
plex with its cognate substrate delineates a tripartite mode of
microtubule recognition mediated by strong ionic interactions
between both a- and b-tubulin C-terminal tails and the TTLL7
core, as well as engagement of the tubulin body by a flexible
cationic microtubule binding domain (c-MTBD) critical for gluta-
mylation activity. Moreover, we discovered analogous cationic
MTBDs required for function in all TTLL family glutamylases
with autonomous activity. Thus, our work provides a detailed
molecular framework to understand microtubule glutamylation,
an essential posttranslational modification conserved from cili-
ates to primates.
RESULTS
X-Ray and EM Analysis of TTLL7 and Its Microtubule
Complex
To elucidate how TTLL7 recognizes the microtubule and mod-
ifies the b-tubulin tail, we employed a hybrid structural approach
combining X-ray crystallography and cryo-EM to determine the
three-dimensional structure of TTLL7 in isolation (Figure 1) as
well as in complex with its cognate substrate, the microtubule
(Figure 2). Homo sapiens TTLL7 constructs (residues 1–518
and residues 36–518, used for cryo-EM and X-ray crystallo-graphic structure determination, respectively; Experimental Pro-
cedures) are active in glutamylating microtubules, resemble a
naturally occurring form of TTLL7 lacking a C-terminal domain
required for ciliary localization (Ikegami et al., 2006; van Dijk
et al., 2007), and, like the longer variant, exhibit a preference
for modifying b-tubulin (Ikegami et al., 2006; Mukai et al., 2009;
van Dijk et al., 2007). The TTLL7 structure is the first reported
for a TTLL family member. The TTLL7-ADP structure was refined
to 2.55-A˚ resolution with a 26.9% Rfree factor (Table S1; Experi-
mental Procedures). Although we co-crystallized TTLL7 with
ADP, ATP, or a slowly hydrolyzable ATP analog (Table S1; Exper-
imental Procedures), there are no significant structural differ-
ences between the resulting structures (root mean-square
deviation [rmsd] <0.3 A˚ over all atoms); the g-phosphate appears
not to be engaged in either the ATP or AMPPNP structures,
possibly because of the absence of the tubulin substrate (see
below).
To investigate the TTLL7-microtubule interaction, we solved
the structure of the enzyme bound to both, heterogeneous
bovine brain tubulin, and human tubulin with no posttranslational
modifications by cryo-EM (Figure S2; Experimental Procedures).
Even though TTLL7 displays 1.8-fold higher affinity for brain
microtubules (Figure S3), the unmodified microtubules yielded
more regular decoration, improving the resolution of the 3D
maps from 10.6 to 7.95 A˚ (Fourier shell correlation criterion at
0.5; Figures 2; Figure S2; Table S2; Experimental Procedures).
EM reconstructions reported to date are of heterogeneous
microtubules generated by randomly repolymerizing tubulin iso-
lated from brain tissue, which contains at least 22 different
charge variants, mostly due to isoform heterogeneity and abun-
dant and variable glutamylation of tubulin tails (Zambito et al.,
2002).
TTLL7 Architecture
Our X-ray structure reveals an elongated TTLL7 core (40 3
60 3 45 A˚3; Figure 1A) consisting of three domains (N-terminal,
central, and C-terminal, residues 36–100, 101–193, and 198–
484, respectively). The TTLL7 core is structurally homologous
to TTL (Szyk et al., 2011; Figures 1B and 1C; all-Ca rmsd =
3.5 A˚) and comprises a central ten-stranded b sheet of mixed
polarity with strands contributed by both the N and C domains,
surrounded by helices from all three domains (Figures 1A; Fig-
ure S1). The TTLL7 core comprises a C-terminal helix (a9) absent
from TTL (Figure 1). This helix packs against the face of the
protein opposite to the active site and is stabilized by forming
a four-helix bundle with helices a3, a4, and a7. It makes exten-
sive apolar knobs-into-holes interactionswith a7 of theC domain
and has amore polar interface with a4 of the central domain (Fig-
ures 1D and 1E). a3, a4, and a7 are also present in TTL; however,
their surface residues are not conserved with TTLL7, consistent
with the absence of a9 in TTL.
In our EM reconstruction, the microtubule-bound TTLL7 was
easily identifiable as a large density spanning the ab-tubulin het-
erodimer into which the TTLL7 X-ray structure could be fitted
with high confidence (UCSF Chimera correlation coefficient
0.85; Figures 2A and 2B; Movie S1). The cryo-EM TTLL7 density
revealed a feature equivalent to 10 kDa closely apposed to the
microtubule shaft. This structural element extends from theCell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc. 1113
Figure 1. Crystal Structure of the Homo
sapiens TTLL7 Core
(A) Ribbon representation of the TTLL7 core bound
to ADP. Nucleotide shown as a stick model.
Spheres represent disordered polypeptide chain
regions. c-MTBD residues, orange spheres.
(B and C) Superposition of TTLL7 and TTL (PDB ID
3TII; gray) crystal structures; (B) nucleotide bind-
ing view, (C) side view, 90 rotated from (B).
(D and E) Close-up views showing residues
important for helix a9 packing with the TTL-
homologous core.
See also Table S1 and Figure S1.ligase core toward the inter-protofilament groove and likely cor-
responds to an 65-amino-acid, cationic insertion (residues
384–450) in the TTLL7 C domain as well as residues immediately
C-terminal to helix a9 (residues 484–518), neither of which are
resolved in the crystal structure of the isolated enzyme (Figures
1A and 2B; Figures S1 and S2G). This newly defined cationic
microtubule-binding domain (c-MTBD) comprises residues
highly conserved in TTLL7 orthologs, but absent from TTL (Fig-
ures 1C and S1). Secondary structure predictions indicate that
the c-MTBD is a-helix rich (Figure S2J). At sub-nanometer reso-
lution, a helices adopt a characteristic sausage-like shape. Such
features are clearly discernible in the density corresponding to
the c-MTBD. Based on secondary structure predictions and
the docked TTLL7 crystal structure, helices were modeled into
these features of the cryo-EM density that account for part of
the c-MTBD (Figures 2B and S2G; Movie S1; Supplemental
Experimental Procedures). Our hybrid structural analysis sug-1114 Cell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc.gests that the c-MTBD is anchored
to the TTLL7 core through helix a9
(Figure 2B).
A Tripartite TTLL7 Interface with
the Microtubule
TTLL7 binds to helices H11 and H12 of
both a- and b-tubulin (Figures 2B and
2C), at a site that partially overlaps with
the microtubule surface used by the mo-
tors kinesin and dynein (Gigant et al.,
2013; Redwine et al., 2012; Rice et al.,
1999; Sindelar and Downing, 2010). Our
EMmapshowsa limited interfacebetween
the TTLL7 core (excluding the c-MTBD)
and the tubulin body that comprises two
main contact points: the loop preceding
TTLL7 helix a5 that interacts with helix
H12 of b-tubulin, and the C-terminal half
of helix a7 that is positioned between
H11 and H12 of a-tubulin. TTLL7 helix a9
lies almost perpendicular to the microtu-
bule interface, with its C terminus pointing
toward the inter-protomer groove at the
center of the tubulin dimer (Figure 2B).
Strikingly, density attributable to both
a- and b-tubulin C-terminal tails is repro-ducibly visible in our cryo-EM maps (Figure 2C). The anionic
b-tubulin tail contacts TTLL7 at the N and central domain junc-
tion with EM density attributable to the b-tail extending toward
the TTLL7 active site, likely guided through interactions with
conserved cationic residues lining the groove between these do-
mains (Figure 2D). In the complex, the TTLL7 active site is more
compact and appears to clamp down around the b-tail,
compared to our crystal structure of the isolated enzyme in
which the active site is open and partially disordered. Nucleotide
(either ATP or ADP) is required for high-affinity binding to the
microtubule as the apo enzyme displays 5-fold lower affinity (Fig-
ure S3G), mostly due to a faster off-rate. Together, these results
suggest a concerted remodeling of the active site that requires
both the nucleotide and tubulin substrates. A similar disorder-
to-order transition is found in TTL, which has an open, partially
disordered active site in the absence of the a-tail (Szyk et al.,
2011), but compacts and closes when engaging both tubulin
Figure 2. Cryo-EM 3D Reconstruction of
TTTL7 Bound to the Microtubule
(A) Surface rendering of the TTLL7-bound micro-
tubule. TTLL7 (gold) spans the ab-tubulin dimer
(silver). The transparent microtubule surface
shows the docked atomic model of tubulin (PDB
ID 1JFF, Lo¨we et al., 2001). a- and b-tubulin,
purple and yellow, respectively.
(B) Boxed area in (A) expanded to show the TTLL7
crystal structure (colored as in Figure 1A) docked
into the cryo-EM density, as well as the modeled
helices in the c-MTBD (orange); tubulin colored as
in (A). Asterisks lie above putative interactions
between the c-MTBD and helix H12 of a-tubulin.
Dashed orange ellipse indicates that the c-MTBD
density extends beyond the partial a-helical
model.
(C) Side view of a protofilament with docked
tubulin and TTLL7 atomic models showing the
interactions between the TTLL7 core and C-ter-
minal tubulin tails of neighboring tubulin dimers.
a- and b-tubulin tails purple and yellow, respec-
tively. TTLL7 colored as in Figure 1A.
(D) Boxed area in (C) expanded to show the in-
teractions between the a- and b-tubulin tails and
the TTLL7 core.
See also Table S2 and Figure S2.and ATP (Prota et al., 2013). In our TTLL7-microtubule complex
structure, the TTLL7 central domain is contacted in trans by the
a-tail of the adjacent tubulin dimer on the same protofilament
(Figures 2C and 2D). The density for the b-tail is better defined
than that for the a-tail, suggesting the latter makes a weaker
interaction with TTLL7.
TTLL7 makes a tripartite interaction with the microtubule. The
flexible a- and b-tails from longitudinally adjacent tubulin dimers
associate with the core of the enzyme, while the TTLL7 c-MTBD
interacts primarily with the a-tubulin protomer of the ab-tubulin
dimer through two main contacts (Figure 2). The N-terminal re-
gion of the c-MTBD likely recognizes the C-terminal half of helix
H12 of a-tubulin, while the C-terminal region interfaces with the
N-terminal portion of a-tubulin helix H12 (Figure 2B). This multi-
pronged microtubule recognition by TTLL7 ensures that the
flexible b-tubulin tail is selectively guided into the active site.Cell 161, 1112–11Consistent with this, TTLL7 modifies
equally well peptides corresponding
either to a or b-tubulin C-terminal se-
quences in isolation, but it preferentially
modifies the b-tubulin tail when pre-
sented in the context of the microtubule
(Figures S3A and S3B). Thus, our hybrid
crystallographic and EM analysis reveals
the structural basis for TTLL7 recognition
of microtubules as well as its preferential
modification of the b-tubulin tail.
Tubulin Tails Are Essential for
TTLL7 Microtubule Recognition
To evaluate the functional significance of
the interactions between the two tubulintails and TTLL7 revealed by our hybrid analysis, we used total in-
ternal reflection fluorescence (TIRF) microscopy and analyzed
the association of GFP-tagged TTLL7 (the activity of GFP-
tagged TTLL7 is similar to that of the untagged enzyme; Figures 3
and S3C) with intact microtubules as well as microtubules lack-
ing either their b-tails, or both a- and b-tails. We find that the
tubulin tails contribute significantly to the binding energy of this
interaction. While TTLL7-GFP shows robust binding to microtu-
bules, proteolytic removal of30% of the b-tubulin tails leads to
a 40% decrease in binding (Figures 3B and 3I). Complete
removal of the b-tails leads to a 74% reduction in binding, while
removal of both a- and b-tails leads to total loss of binding (Fig-
ure 3B). Single-molecule kinetic measurements indicate that
b-tail loss affects both the kon and koff of the enzyme, with the
former affected disproportionally (78% reduction; Figures 3C–
3G). The affinity of TTLL7 for microtubules derived from our23, May 21, 2015 ª2015 Elsevier Inc. 1115
Figure 3. Contribution of Tubulin C-Terminal Tails to TTLL7 Microtubule Binding
(A) Schematic of the microtubule-binding assay. Surface immobilized microtubules and GFP-tagged TTLL7 were imaged by TIRF microscopy.
(B) GFP-tagged TTLL7 was incubated with microtubules (MTs), microtubules missing 30% of their b-tubulin tails (MTs partial Db-tail), microtubules missing all
their b-tubulin tails (MTs Db-tail), and microtubules missing both a- and b-tubulin tails (MTs Da,b-tails) in the presence of 1 mM ATP. TTLL7 normalized fluo-
rescence intensity ±SEM is shown (n = 45, 49, 44 microtubules for MTs, MTs partial Db-tail, and MTs Db-tail, respectively). Representative microtubules and the
corresponding TTLL7 channel are shown. The width of the panels corresponds to 6 mm. Mass spectra for the various microtubules are in (I).
(C) Single-molecule fluorescence analysis. Taxol-stabilizedmicrotubules decoratedwith single TTLL7-GFPmolecules (left) and corresponding kymograph (right).
Scale bars, horizontal, 5 s; vertical, 2 mm.
(D) Distribution of durations of TTLL7-GFP interactionswith themicrotubule. A single-exponential fit to the histogram (corrected for photobleaching) yields amean
lifetime of interaction (t) of 0.85 ± 0.07 s (R2 = 0.9528, n = 807)
(E–G) kon (E), koff (F), and Ka (G) of TTLL7 with various types of microtubules. Error bars indicate SEM. n = 807 for MTs and n = 790 for MTs Db-tails obtained from
four flow cells imaged on different days (Supplemental Experimental Procedures).
(H) TTLL7 binding to microtubules at various ionic strengths.
(I) Mass spectra of the types of microtubules used in assays shown in (B)–(G).
See also Figure S3.single-molecule kon and koff measurements closely matches that
determined from bulk experiments (Kd1.9 mMversus 3 mMwith
brain microtubules; single-molecule and ensemble assays,
respectively; Figures S3E and S3G). Binding of TTLL7 to micro-
tubules missing both C-terminal tails was undetectable at con-
centrations as high as 60 mM, over 20-fold above the Kd of the1116 Cell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc.enzyme for intact microtubules (Figure S3H). Consistent with
the importance of electrostatic interactions, binding between
the highly charged TTLL7 and microtubules is strongly modu-
lated by ionic strength (Figure 3H).
TTLL7 has two distinct but closely related activities. The
enzyme initiates a branched chain from a genetically encoded
Figure 4. Kinetic Analysis of TTLL7 Binding
to Unmodified and Glutamylated Microtu-
bules
(A) kon and koff of the TTLL7 interaction with un-
modified and modified microtubules. Error bars
indicate SEM. n = 1,009 for unmodified MTs;
n = 1,137 for MTs a, b+4.2 Glu obtained from at
least four flow cells imaged on different days
(Supplemental Experimental Procedures).
(B) Mass spectra of the unmodified and glutamy-
lated microtubules used in (A). Number of gluta-
mates on a- and b-tubulin were calculated from
the weighted average of the mass spectra peak
values for the different glutamylated species.
See also Figure S4.internal glutamate of the tubulin tail and also elongates this
branch by addition of subsequent glutamates (Mukai et al.,
2009). We examined how the presence of posttranslationally
added glutamates on microtubules affects TTLL7 binding using
single-molecule TIRF microscopy (Experimental Procedures).
Glutamylation of b-tubulin produces a modest but statistically
significant increase in the kon (28.5%) without affecting the koff
(Figure 4A). The effect on the kon plateaus when the average
number of glutamates on b-tubulin exceeds four (Figures S4A
and S4B). Since favorable electrostatic interactions with the tails
are determinant for TTLL7-microtubule association (Figure 3H),
this falloff suggests that additional glutamates produce steric
hindrance that offsets the favorable electrostatics conferred by
the increased negative charge.
On microtubules with a larger number of glutamates on their
b-tails (8 Glu), TTLL7 exhibits a new behavior. A fraction
(16.7%) of the molecules, rather than associating statically with
the microtubule, undergo one-dimensional diffusion. On hyper-
glutamylated microtubules (28 Glu), this fraction increases to
36.4%. These diffusing molecules scan an average microtubule
length of 0.38 ± 0.04 mm and have a mean microtubule interac-
tion time of 2.6 ± 0.6 s (Figures S4C–S4E). The observed diffusive
binding is independent of the elemental catalysis step as a cat-Cell 161, 1112–11alytic dead mutant also undergoes 1D
diffusion on modified microtubules (Fig-
ure S4H). This observation is consistent
with our interpretation that long glutamate
chains sterically hinder stable TTLL7 as-
sociation with tubulin tails. We speculate
that the observed 1D diffusion could pro-
vide negative feedback for enzyme activ-
ity. It could also be a mechanism for the
enzyme to more effectively find tubulin
tails that are not modified yet. TTLL7
has lower activity on glutamylated micro-
tubules (Mukai et al., 2009).
Molecular Determinants of Tubulin
Tail Recognition
TTLL7 modifies both a- and b-tubulin tail
peptides in isolation (Figure S3A) but
shows preference for the b-tubulin tailwhen presented in the context of the microtubule (Figure S3B).
This suggests that the stereospecificity of the TTLL7 active site
is limited and that the observed in vitro and in vivo selectivity
for the b-tubulin tail must arise from interactions with the micro-
tubule polymer mediated by the c-MTBD and the TTLL7 core.
Such reliance on the contacts with the tubulin body may, in
turn, provide TTLL7 the flexibility to attach multiple glutamates
at multiple positions within the b-tubulin tail (Mukai et al., 2009).
The TTLL7molecular surface shows a high degree of phyloge-
netic conservation and pronounced cationic character, consis-
tent with its interaction with the anionic tails and microtubule
surface (Figure 5). The a-tubulin tail makes limited interactions
with TTLL7, likely contacting residues in a disordered element
connecting strands b7 and b8, and helix a5 (Figure 2D). Accord-
ingly, mutation of invariant Lys178 reduces TTLL7 activity by
44%, while mutation of Asn143 and Lys146 in a5 by 70% (Fig-
ures 5A and 5B). The b-tubulin tail makesmore extensive interac-
tions with the TTLL7 core, consistent with its appearance in the
EM reconstruction and dominant contribution to microtubule
binding affinity (Figure 3). The molecular surface around the
TTLL7 active site aswell as the groove between theN and central
domains that contacts the b-tubulin tail is lined with conserved
lysine and arginine residues (Figures 5C and D). Invariant23, May 21, 2015 ª2015 Elsevier Inc. 1117
Figure 5. Molecular Determinants of Microtubule Glutamylation
(A) Structure of the TTLL7:microtubule complex with conserved TTLL7 residues important for glutamylation denoted by gray spheres. EM surface is shown only
for the microtubule for clarity (compare with Figure 2C). TTLL7 and tubulin colored as in Figures 1A and 2C, respectively. Dashed orange ellipse indicates that the
c-MTBD extends beyond the partial a-helical model shown.
(B) Glutamylation activity of purified structure-guided TTTL7 mutants with taxol-stabilized microtubules. All mutations are in the H. sapiens TTLL7 construct
(residues 1–518). Constructs with other boundaries are in teal. Error bars indicate SEM (nR 3)
(C) TTLL7 molecular surface in the same orientation as in (A) color-coded for conservation on a gradient from white (40% identity) to red (100% identity).
(D) TTLL7 molecular surface in the same orientation as in (A) color-coded for electrostatic potential (red, negative; blue, positive, ranging from 7 kBT to 7 kBT).
(E) TTLL7molecular surface in the same orientation as in (A) color-coded for sequence conservation with TTLL family glutamylases (TTLL1, 4, 5, 6, 7, 9, and 13) on
a gradient from white (40% identity) to red (100% identity).
See also Figure S5.Arg106 and Arg352 line the entrance to this groove and contact
the N-terminal residues of the b-tail (Figures 5A and 5C). Muta-
tion of either to glutamate leads to 93% and 96% loss in activity,
respectively (Figure 5B). Consistent with their importance in
engaging the b-tubulin tail, neither of these mutants can modify
isolated b-tubulin peptides, unlike the wild-type (Figures S5C
and S5F). Interestingly, while Arg106 is conserved across all
TTLs and TTLLs, Arg352 is conserved only in TTLL7 sequences
(Figure 5E), suggesting a specific role for this residue in engaging
the b-tail.
The nucleotide is coordinated by residues from the central and
C domains (Figure 1A) conserved between TTL and all TTLL en-1118 Cell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc.zymes (Figures 5C and 5E), consistent with their common overall
reaction mechanism, ATP-dependent peptide bond formation to
a tubulin tail carboxylate (C-terminal a-carboxylate and internal
g-carboxylate for TTL and TTLLs, respectively). Invariant
Arg202 in TTL coordinates the tubulin tail glutamate (Prota
et al., 2013; Szyk et al., 2011). Mutation of the corresponding
Arg205 in TTLL7 reduces activity to background bothwithmicro-
tubules and b-tail peptide (Figures 5 and S5D). Arg227 likely neu-
tralizes the transition state during phosphate transfer and could
also stabilize the incoming glutamate. Its mutation reduces
TTLL7 activity by 97% (Figure 5B). The equivalent residue is
invariant in all TTLLs and TTL (Szyk et al., 2011), indicative of
Figure 6. A Conserved Microtubule-Binding Domain Critical for
TTLL7 Function
(A) Sequence alignment of the c-MTBD insertion in the TTLL7 C domain from
H. sapiens (Hs),Mus musculus (Mm), Xenopus laevis (Xl), and Danio rerio (Dr).
Residues colored according to conservation as in Figure S1.H. sapiens TTLL7
residue numbers are shown. Cationic residues are in blue.
(B) Microtubule glutamylation (dark gray) and binding (light gray). Gluta-
mylation assays performed as described in Experimental Procedures (nR 3).
Relative microtubule binding affinities were determined from fluorescence
mean intensities (n = 57, 39, 46, and 44 microtubules for wild-type TTLL7 and
the c-MTBD mutants). Error bars indicate SEM.
(C) Michaelis-Menten fit of microtubule glutamylation data for TTLL7 wild-type
and TTLL7 c-MTBD charge-reversal mutant. Error bars represent SE of the fit
(n = 4). The Km and kcat for TTLL7 and c-MTBD charge-reversal mutant are
0.6 ± 0.1 mM, 0.1 ± 0.01 min1 and 4.2 ± 0.7 mM, 0.09 +0.01 min1,
respectively.
(D) Glutamylation activity with isolated bIVb-tubulin peptide for TTLL7 and
c-MTBD deletion mutant (n = 4). Error bars indicate SEM.
See also Figure S6.its essential role. Invariant Lys271 flanks the active site cleft
opposite from the b-tubulin tail entrance channel (Figures 5A,
5C, and 5D). Its mutation to glutamate reduces activity by 99%
(Figures 5B and S5E). Unlike Arg227 that is conserved across
all TTLLs and TTLs, Lys271 is conserved only in glutamylases.
This residue is a glutamate in TTL and does not participate in
a-tail recognition (Prota et al., 2013). The more extended tail
interaction site might reflect the fact that TTLL glutamylases
ligate a glutamate to an internal position in the tubulin tail,
requiring the tail to be engaged on both sides of the targeted
glutamate, as opposed to TTL that ligates tyrosine to the a-tail
carboxyl terminus.
AConservedCationic Domain Important forMicrotubule
Recognition by TTLL7
The c-MTBD binds the a-tubulin body mainly through contacts
with the electronegative surface of helix H12 and the short helix
preceding it. Helix a9 in TTLL7 anchors the C-terminal region ofthe c-MTBD domain (Figure 2). Destabilization of a9 throughmu-
tation of invariant Phe477 and Phe480 (engaged in hydrophobic
interactions with conserved residues in TTLL7 helix a7; Figures
1D and 1E) reduces activity by 40% (Figure 5B). Deletion of
c-MTBD residues 384–446 reduces glutamylation and microtu-
bule binding by 89% and 81%, respectively (Figures 6A and
6B; Figure S6). Conserved lysine and arginine residues consti-
tute 28% of the c-MTBD sequence. Charge reversal of the
first cluster of positive residues decreases binding by 45%.
Charge-reversal mutations of additional positive residues clus-
tered toward the C terminus of the c-MTBD further reduces bind-
ing by 76% (Figures 6A and 6B). This latter charge reversal
mutant also displays a 7.5-fold weaker Km with microtubules
than the wild-type, but only a minor decrease in catalytic rate
(0.1 ± 0.01 versus 0.09 ± 0.01 min1; Figure 6C), indicating that
the main function of this domain is microtubule binding. Consis-
tent with the role of the c-MTBD in engaging the microtubule
body, a mutant missing this domain modifies isolated b-tubulin
peptides at a rate similar to the wild-type (Figure 6D). Similarly,
charge reversal mutations of c-MTBD positively charged resi-
dues located C-terminal to helix a9 (R490D/K497D/R498D/
K500D) reduces activity by 69% (Figure 5B). In contrast, deletion
and charge reversal mutations of positive residues at the N ter-
minus of TTLL7 have no effect (Figures S1 and 5B). Our in vitro
results are recapitulated by studies in living cells: while TTLL7-
GFP shows co-localization with microtubules and strong gluta-
mylation activity when overexpressed in human osteosarcoma
cells (U2OS line), the c-MTBD deletion mutant shows diffuse
cytoplasmic localization and no detectable glutamylation activity
(Figures 7A and 7B).
A Conserved Cationic Region Important for
Glutamylation across TTLL Family Glutamylases
Unlike TTL that tyrosinates monomeric tubulin, TTLL family
members prefer microtubules (Mukai et al., 2009; van Dijk
et al., 2007). To generalize our studies of TTLL7, we carried out
structure-based sequence analyses of all TTLL glutamylases.
This revealed the existence of an insertion in their C domains
at a position similar to that of the TTLL7 c-MTBD (Figure 7A; Fig-
ure S7). The length of this analogous segment ranges between
50 and 80 amino acids, and its composition is heavily biased
toward positively charged residues (Figure 7A). To establish
whether this cationic region important for substrate binding by
TTLL7 contributes to the activity of other glutamylases of the
TTLL family, we expressed internal deletion mutants of this
region of six TTLL glutamylases in human tsa201 cells and deter-
mined their glutamylation activities (Figures 7A and 7C; Experi-
mental Procedures). While wild-type TTLL enzymes exhibited
robust glutamylation activity when overexpressed, the internal
deletion constructs had either severely reduced or background
levels of activity (Figure 7C). To ensure that this was not due to
folding defects caused by the internal deletions (expression of
full-length protein was confirmed for both wild-type and mu-
tants), we also created several charge reversal mutations in
this cationic region. As for the deletions, the charge reversal mu-
tations also reduced the activity of all enzymes to near back-
ground. Thus, our analysis has uncovered a functionally
conserved cationic region that plays a key role in the functionCell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc. 1119
Figure 7. A Cationic Microtubule-Binding Region Critical for Glutamylase Activity
(A) Sequence alignment of the proposed microtubule binding C-domain insertions of M. musculus glutamylases TTLL4, 5, 6, 11, and 13. TTLL7 c-MTBD and
adjacent secondary structure elements are shown at the top. Residues colored according to conservation as in Figure S1. Percentage of cationic residues in the
insertion indicated.
(B) Cellular distribution (green channel) and glutamylation activity (red channel) of H. sapiens wild-type TTLL7 and a c-MTBD deletion mutant. Scale bar, 10 mm.
(C) Glutamylation activity of GFP-tagged wild-type and mutant constructs of TTLL4, 5, 6, 7, 11, and 13 glutamylases as determined by western blot using
antibodies to GFP and glutamylation (nR 3; Experimental Procedures).
Error bars indicate SEM. See also Figure S7.of all TTLL family glutamylases with autonomous glutamylation
activity. We did not find an analogous cationic segment in
TTLL1, 2, and 9. TTLL1 functions as part of a five-subunit com-
plex and does not have glutamylation activity in isolation (Janke
et al., 2005). Similarly, TTLL2 and 9 are not active in isolation and
are thought to function as part of a complex (Kubo et al., 2014;
van Dijk et al., 2007). We did not find an analogous domain in se-
quences of the glycylases TTLL3 and 8. However, we found that
these enzymes contain a charged insertion in their N-terminal
domains that may have an equivalent function.
DISCUSSION
We report the first atomic structure of any enzyme of the TTLL
family. We also present the first structure of any microtubule
posttranslational modification enzyme in complex with its phys-
iological substrate, the microtubule. Because TTL and TTLL en-
zymes share a homologous core, it has been a puzzle since their
initial discovery (Janke et al., 2005) how functional specialization
arises. This specialization is what articulates the tubulin code.
Despite their common fold, TTL modifies monomeric tubulin,
while TTLL7 prefers microtubules. TTL preferentially acts on un-
polymerized tubulin by recognizing an a-tubulin interface
masked in the microtubule polymer. It binds at the edge of the
ab-tubulin dimer and makes contacts mostly with a-tubulin,
guiding the flexible a-tail into its active site (Prota et al., 2013;
Szyk et al., 2011). Because TTL binding occludes an a-tubulin
polymerization interface, it inhibits microtubule assembly (Szyk
et al., 2011, 2013; Prota et al., 2013). Our hybrid structural anal-1120 Cell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc.ysis reveals that TTLL7 augments its TTL homologous core with
a newly defined cationic microtubule-binding domain (Figures 1
and 2) and recognizes the microtubule polymer through multiva-
lent interactions that involve the c-MTBD (absent in TTL), as well
as both a- and b-tubulin tails, the former being provided in trans
by the neighboring dimer on the same protofilament (Figure 2).
TTL displays exquisite specificity for the a-tubulin tail, ligating
a tyrosine only to its C-terminal glutamate (Ru¨diger et al., 1994).
In contrast, TTLL7 catalyzes the addition of glutamates at multi-
ple internal positions in the b-tail, and also that of subsequent
glutamates to existing branched glutamates (Mukai et al.,
2009). While for TTL the interaction with the a-tail is low affinity
but high specificity and additional binding energy is obtained
from engaging the tubulin body (Szyk et al., 2011), for TTLL7
the interaction with the tails contributes predominantly to the
binding affinity (Figure 3) but is more permissive stereochemi-
cally. Specificity for the b-tubulin tail is achieved through addi-
tional contacts with the microtubule (mainly through the
c-MBTD) that position TTLL7 to selectively channel the b-tubulin
tail into the active site. Consistent with the activity of TTLL7 on
b-tail-internal glutamates, the TTLL7 active site is more open
and residues involved in substrate recognition span a greater
distance from the nucleotide-binding site than those of TTL.
Thus, the TTLL7 active site has evolved a higher degree of plas-
ticity to accommodate multiple biochemical activities (addition
of branch-point glutamates at multiple positions, as well as
glutamate chain elongation), while the TTL active site has
evolved to stringently recognize the a-tail and add a single tyro-
sine to its terminal glutamate. Different TTLL family glutamylases
have different substrate preferences (a- or b-tubulin tail). Addi-
tional structural studies of TTLL members with different
substrate specificities will establish whether this strategy of
conferring specificity through interactions with the microtubule
body rather than stringent active site regioselectivity is a general
strategy employed by TTLL family enzymes.
Our analyses show that TTLL7 achieves functional versatility
by employing a three-pronged strategy to recognize themicrotu-
bule: it engages both a- and b-tubulin tails with its TTL homolo-
gous core and uses the flexible c-MTBD to bind the tubulin body.
All three interactions are negotiated between flexible, charged
sequence elements (the anionic C-terminal tails; the cationic
c-MTBD) and stably folded structural elements (the TTLL7
core; the tubulin body). Association through intrinsically disor-
dered regions provides specificity but entails high entropic
cost, thereby producing accurate, but low-affinity interactions
(Dyson and Wright, 2002; reviewed in Roll-Mecak, 2015). The
combined use of folded and intrinsically disordered substrate
recognition elements could be a general mechanism employed
by enzymes that use a single active site to catalyze multiple ster-
eochemically distinct but chemically analogous reactions. The
flexibility of the tubulin tails also likely facilitates a productive
encounter of the enzymewith the rigid microtubule shaft, consis-
tent with the predominant decrease in the kon when they are
removed (Figure 3).
The c-MTBD employed by TTLL7 is present in other TTLL glu-
tamylases with autonomous activity (TTLL4, 5, 6, 11, 13) where it
is critical for function (Figure 7). Among these glutamylases,
TTLL4 also modifies nucleosome-associated proteins (NAPs) 1
and 2 (van Dijk et al., 2008). It remains to be established whether
the c-MTBD also serves to recognize those non-tubulin sub-
strates. Intriguingly, the presence of a disordered glutamate-
rich region in the C terminus of NAPs is not sufficient for glutamy-
lation by TTLL4, and additional regions far removed from the
modification sites are required (van Dijk et al., 2008), suggesting
the involvement of a c-MTBD-like engagement with the globular
core of these NAPs. The equivalent cationic region is absent in
glutamylases TTLL1, 2, and 9, which are thought to function as
part of multi-subunit complexes and lack autonomous glutamy-
lation activity. In these cases, an element analogous to the
c-MTBD might be supplied in trans by their binding partners.
The tripartite recognition mechanism of TTLL7 has notable
parallels with the ‘‘collaborative templating’’ mechanism of the
class I CCA-adding enzyme (Shi et al., 1998). That enzyme
uses non-catalytic domains to position itself on the upper helix
and elbow of tRNA, while its active site unfolds and refolds
around the acceptor end of tRNA for each sequential addition
of CTP and ATP. This strategy allows the enzyme to hold the
tRNA rigidly in place while its active site sequentially engages
and repositions the 30-terminal acceptor end (Tomita and Yama-
shita, 2014). TTLL7 uses interactions with the rigid microtubule
shaft to position itself while its active site can fold and refold to
enable both initiation at different sites in the tubulin tail and elon-
gation of the branches thus formed. This could be a general
mechanism used by enzymes that require distributive selectivity
for their activities. The ability of TTLL7 to initiate and then elon-
gate substrate chains is also reminiscent of poly-(ADP ribose)
polymerases (PARPs). Those enzymes use common catalyticresidues to both initiate and then elongate ADP ribose chains
of varying lengths and branching structures (Gibson and Kraus,
2012). The two reactions are thought to be supported by
differentially positioning the substrates within the active site, a
mechanism that we propose is also operative in TTLL7. A
comprehensive understanding of the kinetics and substrate
recognition strategies of the large family of TTLL enzymes will
enable us to understand the underlying principles that give rise
to the complex microtubule modification patterns observed in
cells as well as derive general design principles of enzyme active
sites with distributive specificities.
EXPERIMENTAL PROCEDURES
Protein Production, Crystallization, and Structure Determination
Details regarding protein purification are in Supplemental Experimental Proce-
dures. For crystallization studies, TTLL7 (36–518) yielded crystals that
were suitable for structure determination. Crystals of apo, ADP, ATP, or
AMPPNP-bound TTLL7 grew at room temperature by hanging drop vapor
diffusion in 0.1 M MES 6.0, 10% PEG 20 K, 5 mM MgCl2, 0.5 mM tris(2-chlor-
oethyl) phosphate (TCEP), and 0.5 mM nucleotide with symmetry of space
group C2221 with one TTLL7 copy in the asymmetric unit. Data from SeMet
and ethyl mercury phosphate (EMP) -soaked TTLL7-AMMPNP crystals were
collected at the Advanced Photon Source beamline 24-ID-E. Detailed proce-
dures for structure determination and refinement can be found in Table S1
and Supplemental Experimental Procedures. Native data sets for ADP and
TTLL7-AMPPNP were collected at Advanced Light Source beamlines 5.0.1
and 5.0.2, respectively. The structure of ADP-bound TTLL7 was solved bymo-
lecular replacement. The current TTLL7-ADP crystallographic model at 2.55-A˚
resolution has Rwork and Rfree of 22.2% and 26.9%, respectively (Table S1),
with no unfavorable (f,c) combinations. The current TTLL7-AMPPNP crystal-
lographic model at 2.60-A˚ resolution has Rwork and Rfree of 21.0% and 24.6%,
respectively (Table S1), with no unfavorable (f,c) combinations.
Cryo-EM 3D Reconstruction
Undecorated 14 and 15 protofilament microtubule densities (Sui and Downing,
2010) were used as initial models for all preliminary reconstructions. The
IHRSR (Egelman, 2007) procedure was used for multi-model projection
matching of microtubule specimens with varying numbers of protofilaments
(Alushin et al., 2014). A final refinement of the microtubule segment alignment
parameters was performed in FREALIGN (Grigorieff, 2007) without further
refinement of helical parameters. Fourier Shell Correlation (FSC) curves for
microtubule reconstructions were used to estimate resolutions of each recon-
struction using a cutoff of 0.5 (Figure S2E). In order tomore accurately estimate
the resolution of each region of the reconstructed density, a local resolution
calculation was performed using the ‘‘blocres’’ and ‘‘blocfilt’’ functions in the
Bsoft processing package (Heymann and Belnap, 2007). This analysis re-
vealed that the majority of the tubulin density is in the range of 7–8 A˚, while
the ligase portion ranges from 9- to 12-A˚ resolution. Details regarding cryo-
EM data collection, processing, and 3D reconstruction are in Supplemental
Experimental Procedures; Table S2; Figure S2.
Glutamylation Assays
Glutamylation activity was measured through [3H]-glutamate incorporation.
Assays are described in Supplemental Experimental Procedures.
Mass-Spectrometry-Based Glutamylation Assays
Mass spectrometric analysis of glutamylation reactions is described in detail in
Supplemental Experimental Procedures. Samples were analyzed by electro-
spraymass spectrometry as described in Vemu et al. (2014) and Supplemental
Experimental Procedures.
Single-Molecule TIRF Analysis
Chambers were assembled as in Szyk et al. (2014). For single-molecule kinetic
measurements, TTLL7-GFP was perfused in assay buffer supplemented withCell 161, 1112–1123, May 21, 2015 ª2015 Elsevier Inc. 1121
oxygen scavengers prepared as in Zio´lkowska and Roll-Mecak (2013). A com-
plete description of data collection and analyses can be found in Supplemental
Experimental Procedures.
ACCESSION NUMBERS
Protein Data Bank accession numbers for atomic coordinates and structure
factor amplitudes are 4YLR and 4YLS. The EMDB accession code for the
TTLL7:microtubule complex structure is EMD-6307.
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Supplemental Information includes Supplemental Experimental Procedures,
seven figures, two tables, and one movie and can be found with this article
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